| Autor: |
K V, Zhdanov, D A, Gusev, K V, Kozlov, M K, Shishkin, V S, Sukachev, D M, Shakhmanov, S S, Zhabrov |
| Rok vydání: |
2015 |
| Předmět: |
|
| Zdroj: |
Voenno-meditsinskii zhurnal. 336(4) |
| ISSN: |
0026-9050 |
| Popis: |
In order to evaluate effectiveness and safety of antiviral therapy schemes examined and treated 191 patients with chronic bepatitis C were assigned standard interferon and ribavirin, pegslated interferon and ribavirin, the total duration of the course coput 24-48 weeks. Based on clinical and laboratory parameters evaluated the safety of antiviral therapy. Formation of sustainable viral response, depending on the genotype observed, was given at 58,9-70%.of patients. In case of insufficient. antiviral therapy was prescribed a second course that will improve the effectiveness of treatment to 90-95%. Correction of adverse events was held lower dosages of interferon and/or ribavirin. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
